<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2294">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04361448</url>
  </required_header>
  <id_info>
    <org_study_id>20.43</org_study_id>
    <nct_id>NCT04361448</nct_id>
  </id_info>
  <brief_title>Performance of 3 Sampling Methods for the Detection of SARS-CoV-2 (COVID-19) With Real-time Reverse Transcriptase PCR</brief_title>
  <official_title>Comparison of the Performance of 3 Sampling Methods for the Detection of SARS-CoV-2 (COVID-19) With Real-time Reverse Transcriptase PCR</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jessa Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Jessa Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The performance of 3 different sampling methods (2 nasopharyngeal swabs, 1 oropharyngeal
      swab) for the detection of SARS-CoV-2 with real-time reverse transcriptase polymerase chain
      reaction will be compared.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Thirty volunteers will be recruited from health care workers suspicious for Covid-19, who
      consult the ocupational physician for Covid-19 testing.

      For each volunteer, 3 swabs will be taken:

        -  Flocked eSwab (Copan, Italy) of the oropharynx

        -  Flocked nasopharyngeal eSwab (Copan, Italy) of the nasopharynx

        -  Dry flocked nasopharyngeal Swab, placed in lysis buffer Each swab will be tested for the
           presence of SARS-CoV-2 with an in-house reverse-transcriptase real-time PCR (Egene).

      Performance of each method will be calculated.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 20, 2020</start_date>
  <completion_date type="Anticipated">May 20, 2020</completion_date>
  <primary_completion_date type="Anticipated">May 20, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Beside the regular sampling method of 1 nasopharyngeal swab, 2 extra swabs will be taken in each volunteer. Performance of the 3 methods for laboratory diagnosis by PCR of Covid-19 will be compared.</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Each participant get study number. Samples will be identified by the study number.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>sensitivity</measure>
    <time_frame>1 month</time_frame>
    <description>sensitivity of each sampling method for the detection of SARS-CoV-2 by RT-PCR</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Covid-19</condition>
  <condition>SARS-CoV-2</condition>
  <condition>Diagnosis</condition>
  <condition>Polymerase Chain Reaction</condition>
  <arm_group>
    <arm_group_label>Health Care Workers with Covid-19 symptoms</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>3 samples (2 nasopharyngeasl swabs, 1 oropharyngeal swab) willl be taken from each volunteer</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>samling of oropharynx and nasopharynx</intervention_name>
    <description>Three different swabs will be taken of each participant: 1 oropharyngeal swab and 2 nasopharyngeal swabs</description>
    <arm_group_label>Health Care Workers with Covid-19 symptoms</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  health care workers with symptoms suspicious for Covid-19

        Exclusion Criteria:

          -  none
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Reinoud Cartuyvels</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jessa Hospital, Hasselt, Belgium</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Reinoud Cartuyvels</last_name>
    <phone>+3211338200</phone>
    <email>reinoud.cartuyvels@jessazh.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Koen Magerman</last_name>
    <phone>+3211338200</phone>
    <email>koen.magerman@jessazh.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Jessa Hospital</name>
      <address>
        <city>Hasselt</city>
        <zip>3500</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 20, 2020</study_first_submitted>
  <study_first_submitted_qc>April 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 24, 2020</study_first_posted>
  <last_update_submitted>April 22, 2020</last_update_submitted>
  <last_update_submitted_qc>April 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Jessa Hospital</investigator_affiliation>
    <investigator_full_name>Reinoud Cartuyvels</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

